1
|
Axonal damage markers in cerebrospinal fluid are increased in ALS.
|
Neurology
|
2006
|
1.69
|
2
|
Cerebrospinal fluid proteome profile in multiple sclerosis.
|
Mult Scler
|
2007
|
0.87
|
3
|
Tau protein level in cerebrospinal fluid is increased in patients with early multiple sclerosis.
|
Mult Scler
|
2005
|
0.83
|
4
|
The advanced glycation end-product N epsilon-(carboxymethyl)lysine level is elevated in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
|
Neurosci Lett
|
2004
|
0.78
|
5
|
Proteome analysis of cerebrospinal fluid in Guillain-Barré syndrome (GBS).
|
J Neuroimmunol
|
2007
|
0.78
|
6
|
Respiratory dysfunction in sleep apnea associated with quetiapine.
|
Pharmacopsychiatry
|
2008
|
0.76
|